SUMMER DEVOL: Open Payments
NPI 1326701251 · PARKERSBURG, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,234 in 87 payments from 13 companies in 2025. Trend: 2023 $1,186 · 2024 $739 · 2025 $1,234
Food & beverage: $1,234
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 23 | $364 |
| ABBVIE INC. | 27 | $242 |
| Otsuka America Pharmaceutical, Inc. | 12 | $182 |
| Teva Pharmaceuticals USA, Inc. | 5 | $99 |
| Vanda Pharmaceuticals Inc. | 3 | $61 |
| Alkermes, Inc. | 3 | $59 |
| Axsome Therapeutics, Inc. | 3 | $49 |
| Collegium Pharmaceutical, Inc. | 3 | $48 |
| Janssen Pharmaceuticals, Inc | 3 | $46 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $28 |
Products named: CAPLYTA, VRAYLAR, REXULTI, AUSTEDO XR, FANAPT, ARISTADA, Auvelity, Jornay PM.
Industry payments across WV — which companies pay providers there.
